RIO DE JANEIRO – Brazil’s health regulator on Sunday approved the urgent use of coronavirus vaccines made by Sinovac and AstraZeneca, enabling Latin America’s largest nation to begin an immunization program that’s been subject to months of delay and political disputes.
Brazil currently has 6 million doses of Sinovac’s CoronaVac vaccine ready to distribute in the next few days, and is awaiting the arrival of another 2 million doses of the vaccine made by AstraZeneca and partner Oxford University.
On Saturday night, the health regulator Anvisa rejected an application for use of a Russian vaccine called Sputnik V, submitted by Brazilian company União Química.